-
Innovation Ranking
NewInnovation Ranking – Han’s Laser Technology Industry Group Co., Ltd.
Hans Laser Technology Industry Group Co Ltd (Han’s Laser) is a manufacturer of laser equipment. Its products include laser marking machines, laser welding machines, laser cutting machines, automation machines, inspection machines,3D printers, CNC, and collaborative robots, among others. The company serves various industries such as information technology, automotive, packaging, components, sheet metal, mechanical hardware, energy, and electronic and semiconductor, among others. Han’s Laser also provides installation and after sales services. It operates in North America, South America, Asia, Europe, the...
-
Product Insights
Nong Han
Nong Han is a biopower project located in Udon Thani, Thailand. The project is owned and being developed by Thaico Technology Co Ltd. The project is expected to come online in 2027. Empower your strategies with our Nong Han report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
Inner Mongolia Chifeng Han Shan Datang Wind Farm
Inner Mongolia Chifeng Han Shan Datang Wind Farm is an onshore wind project located in Inner Mongolia, China. The project is owned and developed by China Datang Corp. The project came online in 2015. Empower your strategies with our Inner Mongolia Chifeng Han Shan Datang Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Biosimilar in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab Biosimilar in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Biosimilar in Gastric Cancer Drug Details: Trastuzumab biosimilar (Zercepac/ Han...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Biosimilar in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab Biosimilar in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Biosimilar in Adenocarcinoma Of The Gastroesophageal Junction...
-
Product Insights
Acute Coronary Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Coronary Syndrome - Drugs In Development, 2023’, provides an overview of the Acute Coronary Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Coronary Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Drugs In Development, 2023’, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDB-201 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDB-201 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDB-201 in Solid Tumor Drug Details: Orien X-010 (BDB-201) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDB-201 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDB-201 in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDB-201 in Melanoma Drug Details: Orien X-010 (BDB-201) is under development for the...